HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 75 filers reported holding HARROW HEALTH INC in Q3 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278,218 | +19.0% | 19,361 | +57.7% | 0.00% | – |
| Q2 2023 | $233,716 | +238.3% | 12,275 | +276.0% | 0.00% | – |
| Q1 2023 | $69,087 | +788.1% | 3,265 | +519.5% | 0.00% | – |
| Q4 2022 | $7,779 | -100.0% | 527 | -67.5% | 0.00% | – |
| Q3 2022 | $19,578,000 | +272.5% | 1,622 | +124.7% | 0.00% | – |
| Q2 2022 | $5,256,000 | -6.5% | 722 | -12.4% | 0.00% | – |
| Q1 2022 | $5,620,000 | +54.1% | 824 | +95.3% | 0.00% | – |
| Q4 2021 | $3,646,000 | -11.1% | 422 | -6.4% | 0.00% | – |
| Q3 2021 | $4,100,000 | -24.0% | 451 | -22.4% | 0.00% | – |
| Q2 2021 | $5,397,000 | -76.8% | 581 | -83.1% | 0.00% | – |
| Q1 2021 | $23,220,000 | -47.9% | 3,440 | -47.0% | 0.00% | – |
| Q4 2020 | $44,556,000 | +49.6% | 6,495 | +21.9% | 0.00% | – |
| Q3 2020 | $29,784,000 | +582.2% | 5,328 | +535.8% | 0.00% | – |
| Q2 2020 | $4,366,000 | – | 838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,065,416 | $21,029,000 | 2.75% |
| Diametric Capital, LP | 252,774 | $1,734,000 | 1.38% |
| Birchview Capital, LP | 180,000 | $1,235,000 | 0.71% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 118,389 | $812,000 | 0.61% |
| Zebra Capital Management LLC | 58,062 | $398,000 | 0.50% |
| Precision Wealth Strategies, LLC | 62,739 | $430,000 | 0.47% |
| Sio Capital Management, LLC | 209,623 | $1,438,000 | 0.29% |
| Uniplan Investment Counsel, Inc. | 505,746 | $3,469,000 | 0.24% |
| CORRADO ADVISORS, LLC | 31,580 | $217,000 | 0.17% |
| BARD ASSOCIATES INC | 287,250 | $1,970,000 | 0.16% |